128 related articles for article (PubMed ID: 28772051)
1. Protocol update and preliminary results of EACVI/HFA Cardiac Oncology Toxicity (COT) Registry of the European Society of Cardiology.
Lancellotti P; Galderisi M; Donal E; Edvardsen T; Popescu BA; Farmakis D; Filippatos G; Habib G; Lestuzzi C; Santoro C; Moonen M; Jerusalem G; Andarala M; Anker SD;
ESC Heart Fail; 2017 Aug; 4(3):312-318. PubMed ID: 28772051
[TBL] [Abstract][Full Text] [Related]
2. EACVI/HFA Cardiac Oncology Toxicity Registry in breast cancer patients: rationale, study design, and methodology (EACVI/HFA COT Registry)--EURObservational Research Program of the European Society of Cardiology.
Lancellotti P; Anker SD; Donal E; Edvardsen T; Popescu BA; Farmakis D; Filippatos G; Habib G; Maggioni AP; Jerusalem G; Galderisi M
Eur Heart J Cardiovasc Imaging; 2015 May; 16(5):466-70. PubMed ID: 25744342
[TBL] [Abstract][Full Text] [Related]
3. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC).
Čelutkienė J; Pudil R; López-Fernández T; Grapsa J; Nihoyannopoulos P; Bergler-Klein J; Cohen-Solal A; Farmakis D; Tocchetti CG; von Haehling S; Barberis V; Flachskampf FA; Čeponienė I; Haegler-Laube E; Suter T; Lapinskas T; Prasad S; de Boer RA; Wechalekar K; Anker MS; Iakobishvili Z; Bucciarelli-Ducci C; Schulz-Menger J; Cosyns B; Gaemperli O; Belenkov Y; Hulot JS; Galderisi M; Lancellotti P; Bax J; Marwick TH; Chioncel O; Jaarsma T; Mullens W; Piepoli M; Thum T; Heymans S; Mueller C; Moura B; Ruschitzka F; Zamorano JL; Rosano G; Coats AJS; Asteggiano R; Seferovic P; Edvardsen T; Lyon AR
Eur J Heart Fail; 2020 Sep; 22(9):1504-1524. PubMed ID: 32621569
[TBL] [Abstract][Full Text] [Related]
4. Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13.
Drugs R D; 2005; 6(3):178-85. PubMed ID: 15869322
[TBL] [Abstract][Full Text] [Related]
5. Impact of Arterial Hypertension on Doxorubicin-Based Chemotherapy-Induced Subclinical Cardiac Damage in Breast Cancer Patients.
Vaitiekus D; Muckiene G; Vaitiekiene A; Maciuliene D; Vaiciuliene D; Ambrazeviciute G; Sereikaite L; Verikas D; Jurkevicius R; Juozaityte E
Cardiovasc Toxicol; 2020 Jun; 20(3):321-327. PubMed ID: 31782105
[TBL] [Abstract][Full Text] [Related]
6. SAFE-HEaRt: Rationale and Design of a Pilot Study Investigating Cardiac Safety of HER2 Targeted Therapy in Patients with HER2-Positive Breast Cancer and Reduced Left Ventricular Function.
Lynce F; Barac A; Tan MT; Asch FM; Smith KL; Dang C; Isaacs C; Swain SM
Oncologist; 2017 May; 22(5):518-525. PubMed ID: 28314836
[TBL] [Abstract][Full Text] [Related]
7. Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study.
Lynce F; Barac A; Geng X; Dang C; Yu AF; Smith KL; Gallagher C; Pohlmann PR; Nunes R; Herbolsheimer P; Warren R; Srichai MB; Hofmeyer M; Cunningham A; Timothee P; Asch FM; Shajahan-Haq A; Tan MT; Isaacs C; Swain SM
Breast Cancer Res Treat; 2019 Jun; 175(3):595-603. PubMed ID: 30852761
[TBL] [Abstract][Full Text] [Related]
8. Approach to cardio-oncologic patients with special focus on patients with cardiac implantable electronic devices planned for radiotherapy: results of the European Heart Rhythm Association survey.
Lenarczyk R; Potpara TS; Haugaa KH; Deharo JC; Hernandez-Madrid A; Del Carmen Exposito Pineda M; Kiliszek M; Dagres N
Europace; 2017 Sep; 19(9):1579-1584. PubMed ID: 28934410
[TBL] [Abstract][Full Text] [Related]
9. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation.
Badano LP; Miglioranza MH; Edvardsen T; Colafranceschi AS; Muraru D; Bacal F; Nieman K; Zoppellaro G; Marcondes Braga FG; Binder T; Habib G; Lancellotti P;
Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):919-48. PubMed ID: 26139361
[TBL] [Abstract][Full Text] [Related]
10. [Hungarian Heart Failure Registry 2015-2016. Preliminary results].
Nyolczas N; Heltai K; Borbély A; Habon T; Járai Z; Sziliczei E; Stadler P; Faludi R; Herczeg B; Papp E; Lakatos F; Nagy K; Katona A; Kovács I; Tomcsányi J; Nagy A; Sepp R
Orv Hetil; 2017 Jan; 158(3):94-100. PubMed ID: 28110567
[TBL] [Abstract][Full Text] [Related]
11. Heart Failure Association-International Cardio-Oncology Society Risk Score Validation in HER2-Positive Breast Cancer.
Cronin M; Crowley A; Davey MG; Ryan P; Abdelshafy M; Elkoumy A; Elzomor H; Arsang-Jang S; Ganly S; Nash P; Crowley J; Sharif F; Simpkin A; Lowery A; Wijns W; Kerin M; Soliman O
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835818
[TBL] [Abstract][Full Text] [Related]
12. Rationale and design of the multidisciplinary team IntervenTion in cArdio-oNcology study (TITAN).
Pituskin E; Haykowsky M; McNeely M; Mackey J; Chua N; Paterson I
BMC Cancer; 2016 Sep; 16(1):733. PubMed ID: 27629548
[TBL] [Abstract][Full Text] [Related]
13. The European Association of Cardiovascular Imaging/Heart Failure Association Cardiac Oncology Toxicity Registry: long-term benefits for breast cancer treatment.
Jerusalem G; Moonen M; Freres P; Lancellotti P
Future Oncol; 2015; 11(20):2791-4. PubMed ID: 26344798
[No Abstract] [Full Text] [Related]
14. Corrigendum to 'Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)' [Eur J Heart Fail 2020;22:1504-1524].
Eur J Heart Fail; 2021 Feb; 23(2):345. PubMed ID: 33783083
[No Abstract] [Full Text] [Related]
15. Early Detection of Cardiovascular Changes After Radiotherapy for Breast Cancer: Protocol for a European Multicenter Prospective Cohort Study (MEDIRAD EARLY HEART Study).
Walker V; Crijns A; Langendijk J; Spoor D; Vliegenthart R; Combs SE; Mayinger M; Eraso A; Guedea F; Fiuza M; Constantino S; Tamarat R; Laurier D; Ferrières J; Mousseaux E; Cardis E; Jacob S
JMIR Res Protoc; 2018 Oct; 7(10):e178. PubMed ID: 30274965
[TBL] [Abstract][Full Text] [Related]
16. EURObservational Research Programme: a worldwide registry on peripartum cardiomyopathy (PPCM) in conjunction with the Heart Failure Association of the European Society of Cardiology Working Group on PPCM.
Sliwa K; Hilfiker-Kleiner D; Mebazaa A; Petrie MC; Maggioni AP; Regitz-Zagrosek V; Schaufelberger M; Tavazzi L; van Veldhuisen DJ; Roos-Hesslink JW; Shah AJ; Seferovic PM; Elkayam U; van Spaendonck-Zwarts K; Bachelier-Walenta K; Mouquet F; Kraigher-Krainer E; Hall R; Ponikowski P; McMurray JJ; Pieske B
Eur J Heart Fail; 2014 May; 16(5):583-91. PubMed ID: 24591060
[TBL] [Abstract][Full Text] [Related]
17. Emerging Cardiac Imaging Modalities for the Early Detection of Cardiotoxicity Due to Anticancer Therapies.
López-Fernández T; Thavendiranathan P
Rev Esp Cardiol (Engl Ed); 2017 Jun; 70(6):487-495. PubMed ID: 28189542
[TBL] [Abstract][Full Text] [Related]
18. Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy.
Virani SA; Dent S; Brezden-Masley C; Clarke B; Davis MK; Jassal DS; Johnson C; Lemieux J; Paterson I; Sebag IA; Simmons C; Sulpher J; Thain K; Thavendiranathan P; Wentzell JR; Wurtele N; Côté MA; Fine NM; Haddad H; Hayley BD; Hopkins S; Joy AA; Rayson D; Stadnick E; Straatman L
Can J Cardiol; 2016 Jul; 32(7):831-41. PubMed ID: 27343741
[TBL] [Abstract][Full Text] [Related]
19. Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI).
Nunes MCP; Badano LP; Marin-Neto JA; Edvardsen T; Fernández-Golfín C; Bucciarelli-Ducci C; Popescu BA; Underwood R; Habib G; Zamorano JL; Saraiva RM; Sabino EC; Botoni FA; Barbosa MM; Barros MVL; Falqueto E; Simões MV; Schmidt A; Rochitte CE; Rocha MOC; Ribeiro ALP; Lancellotti P
Eur Heart J Cardiovasc Imaging; 2018 Apr; 19(4):459-460n. PubMed ID: 29029074
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
